Christine CPA - Prestige Brand Chief Officer
| PBH Stock | USD 84.14 1.47 1.78% |
Executive
Christine CPA is Chief Officer of Prestige Brand Holdings
| Age | 48 |
| Address | 660 White Plains Road, Tarrytown, NY, United States, 10591 |
| Phone | 914 524 6800 |
| Web | https://www.prestigebrands.com |
Prestige Brand Management Efficiency
The company has Return on Asset of 0.0612 % which means that on every $100 spent on assets, it made $0.0612 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1261 %, implying that it generated $0.1261 on every 100 dollars invested. Prestige Brand's management efficiency ratios could be used to measure how well Prestige Brand manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Prestige Brand's Return On Tangible Assets are increasing as compared to previous years. The Prestige Brand's current Return On Assets is estimated to increase to 0.07, while Return On Capital Employed is projected to decrease to 0.06. As of now, Prestige Brand's Return On Assets are increasing as compared to previous years.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| SANJAY SHARMA | Dr Reddys Laboratories | 52 | |
| Christopher Young | Pacira BioSciences, | 52 | |
| Jayanth Sridhar | Dr Reddys Laboratories | 53 | |
| Sumera Hasham | Dr Reddys Laboratories | N/A | |
| Sandra Coombs | Alkermes Plc | N/A | |
| Krista Davis | ANI Pharmaceuticals | 50 | |
| Richa Periwal | Dr Reddys Laboratories | N/A | |
| Dan MBA | Amphastar P | N/A | |
| YUGANDHAR PUVVALA | Dr Reddys Laboratories | 48 | |
| Charles Laranjeira | Pacira BioSciences, | 58 | |
| Kristen JD | Pacira BioSciences, | 50 | |
| Richard Kahr | Pacira BioSciences, | N/A | |
| Blair Jackson | Alkermes Plc | 51 | |
| Paul Surdez | Catalent | N/A | |
| Esq III | Pacira BioSciences, | 50 | |
| David McErlane | Catalent | 51 | |
| Vivek Mittal | Dr Reddys Laboratories | N/A | |
| Sauri Gudlavalleti | Dr Reddys Laboratories | 42 | |
| Ori Gutwerg | ANI Pharmaceuticals | 49 | |
| Lisa Evoli | Catalent | 54 | |
| Shawn Cross | Pacira BioSciences, | 56 | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0612 |
Prestige Brand Holdings Leadership Team
Elected by the shareholders, the Prestige Brand's board of directors comprises two types of representatives: Prestige Brand inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Prestige. The board's role is to monitor Prestige Brand's management team and ensure that shareholders' interests are well served. Prestige Brand's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Prestige Brand's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Byom, Independent Director | ||
| Gary Costley, Lead Independent Director | ||
| William PPool, Senior Vice President General Counsel and Corporate Secretary | ||
| Christine CPA, Chief Officer | ||
| Jeffrey Zerillo, Senior Vice President Operations | ||
| Christopher Coughlin, Independent Director | ||
| Philip CFA, Director Relations | ||
| Adel Mekhail, Executive Vice President - Sales and Marketing | ||
| Christine Sacco, Chief Financial Officer | ||
| Sheila Hopkins, Independent Director | ||
| Natale Ricciardi, Independent Director | ||
| William JD, General VP | ||
| Ronald Lombardi, Chairman of the Board, President, Chief Executive Officer | ||
| Dawn Zier, Independent Director | ||
| Ronald CPA, President Chairman | ||
| Philip Terpolilli, Director Relations | ||
| Celeste Clark, Independent Director | ||
| Mary Fritz, Senior Affairs | ||
| James Jenness, Independent Director | ||
| Dean Siegal, Director Communications |
Prestige Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Prestige Brand a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0612 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.30 % | ||||
| Current Valuation | 5.08 B | ||||
| Shares Outstanding | 49.41 M | ||||
| Shares Owned By Insiders | 1.30 % | ||||
| Shares Owned By Institutions | 98.70 % | ||||
| Number Of Shares Shorted | 2.37 M | ||||
| Price To Earning | 18.23 X |
Currently Active Assets on Macroaxis
When determining whether Prestige Brand Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prestige Brand's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prestige Brand Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prestige Brand Holdings Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prestige Brand Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prestige Brand. If investors know Prestige will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prestige Brand listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.019 | Earnings Share 4.1 | Revenue Per Share 22.312 | Quarterly Revenue Growth (0.01) | Return On Assets 0.0612 |
The market value of Prestige Brand Holdings is measured differently than its book value, which is the value of Prestige that is recorded on the company's balance sheet. Investors also form their own opinion of Prestige Brand's value that differs from its market value or its book value, called intrinsic value, which is Prestige Brand's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prestige Brand's market value can be influenced by many factors that don't directly affect Prestige Brand's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prestige Brand's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prestige Brand is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prestige Brand's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.